Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Handelsbanken Fonder AB

Handelsbanken Fonder AB raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 41.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,900 shares of the company’s stock after acquiring an additional 10,300 shares during the quarter. Handelsbanken Fonder AB’s holdings in Henry Schein were worth $2,544,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HSIC. Summit Securities Group LLC purchased a new stake in shares of Henry Schein in the second quarter valued at $31,000. Beach Investment Counsel Inc. PA acquired a new stake in shares of Henry Schein during the 2nd quarter worth about $37,000. Blue Trust Inc. grew its holdings in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after buying an additional 475 shares in the last quarter. Mather Group LLC. raised its position in shares of Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after buying an additional 216 shares during the last quarter. Finally, Palisade Asset Management LLC purchased a new position in shares of Henry Schein during the first quarter valued at approximately $113,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on the stock. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. JPMorgan Chase & Co. decreased their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Friday, September 20th. Finally, Evercore ISI raised their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of “Hold” and an average target price of $77.50.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

Henry Schein Trading Up 0.7 %

Shares of HSIC stock opened at $70.51 on Thursday. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The firm’s 50 day moving average price is $70.03 and its two-hundred day moving average price is $70.02. The stock has a market cap of $9.03 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same period in the prior year, the company earned $1.31 EPS. The firm’s revenue was up .0% on a year-over-year basis. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.